Komori
Pharma Foods International (2929) · RiskFirst stated

Obsolescence of Research Achievements Due to Technological Innovation

First written in FY2019. . Latest entry: FY2019.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Product Obsolescence Due to Intensified Competition and Delays in Adapting to TechnologyA theme 122 companies write about · 125 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 28 of 56 companies on the "Worse" side.

8 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 121 companies compared. The sentences above are computed from all 121.
Full recordFilings, disclosures and news, newest first
  1. FY2019First statedAnnual report

    「If the group’s research results become obsolete as a result of the progress of technological innovation by other companies, this may affect the group’s business development and operating performance.」

    The group discloses the possibility that its research results may become obsolete as a result of technological innovation by other companies.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Pharma Foods International yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Obsolescence of Research Achievements Due to Technological Innovation | Pharma Foods International Co.,Ltd. (2929) | Komori